Dang nothing, you are trying to defend the indefensible. This is...

Dang nothing, you are trying to defend the indefensible. This is about PMT, not any other company. Those other companies are required to provide quarterly reports, as such and as I have mentioned in a previous post, 1 or 2 months seem to be the norm. Ken knows the ASX reporting guidelines, as does Blair being domiciled in Australia. They both know Au investors know little about what FQ3 means - this is misleading and retail, along with certain other investors will take the 8 May announcement to imply that PMT has 106 million. Crap, and I hope its rectified by the ASX in the future between Sedar and ASX guidelines.

Continue, if you want to talk about other companies. its about PMT and over the last week I have been contacted on X by pissed shareholders of PMT about numerous disclosure issues i have mentioned.

As for Cv13, i dont agree that cross section should have been provided with the commentary, its my opinion. As i wrote many posts ago, it may very well be a flat lying peg, but it may not. It was a pump ann based on previous poor results to proceed a CR. That assay receipt, along with the remaining two should have been announced together. Market is assuming the best, if it misses, PMT get punished. Its an opinion, unlike PMT needing a CR raise and being deliberately misleading with the Macquarie Presentation about its current cash position.